NNBC-3 Europe study: a trial to improve risk estimation and risk adapted adjuvant chemotherapy in node negative breast cancer patients by using new uPA and PAI-1 and to analise the efficacy of a sequential FEC-taxane chemotherapy versus a standard FEC-chemotherapy regimen

✍ Scribed by F Herbst; N Harbeck; V.P.R Mueller; A Oben; C Meisner; F Sweep; M Schmitt; F Jaenicke; C Thomssen

• Book ID: 118622020
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 171 KB
• Volume: 2
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(04)90672-6